Post by selluwud on Aug 24, 2016 19:35:34 GMT
Mylan's price increase on the epipen has caused a stir.
"2:49 pm Biotech (XBI -2.3%, IBB -2%) stocks under pressure on renewed scrutiny over drug price increases from Democratic Presidential nominee Hillary Clinton; Mylan's (MYL) EpiPens are the culrpit (IBB)"
biotechs are under siege, watch your holdings. What they don't tell you is that the medicare co-pay allowance was lowered which is partly to blame for rising cost.
"2:49 pm Biotech (XBI -2.3%, IBB -2%) stocks under pressure on renewed scrutiny over drug price increases from Democratic Presidential nominee Hillary Clinton; Mylan's (MYL) EpiPens are the culrpit (IBB)"
biotechs are under siege, watch your holdings. What they don't tell you is that the medicare co-pay allowance was lowered which is partly to blame for rising cost.
